Sector ratings Merck KGaA

Equities

Real-time Estimate Tradegate Other stock markets 13:44:21 12/12/2025 GMT			5-day change	1st Jan Change
117.65 ^EUR	-1.01%		-2.40%	-15.83%

12-11	Merck KGaA's SpringWorks Gets UK Clearance for Plexiform Neurofibromas Therapy	MT
12-11	UK's MHRA approves mirdametinib to treat plexiform neurofibromas	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
MERCK KGAA	60.86B		AAA
KYOWA KIRIN CO., LTD.	8.52B		AA
HALOZYME THERAPEUTICS, INC.	7.28B		BBB
SK BIOPHARMACEUTICALS CO., LTD.	7.22B		AAA
YUHAN CORPORATION	5.89B		AA
INDIVIOR PLC	4.47B	-	BBB	-		-
BETTA PHARMACEUTICALS CO., LTD.	2.87B		-
SUPERNUS PHARMACEUTICALS, INC.	2.67B	-	BB	-		-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	2.48B	-	-	-		-	-	-
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	1.95B	-	-	-		-	-	-
VELOXIS PHARMACEUTICALS A/S	1.64B	-	-	-	-	-	-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	1.64B	-	-	-		-	-
MEZZION PHARMA CO.,LTD.	1.53B	-	BBB	-	-	-	-	-
OSCOTEC INC.	1.56B		B
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	1.69B	-	-	-		-	-	-
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	1.33B	-	-	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.	1.22B		BB			-
CHANGCHUN BCHT BIOTECHNOLOGY CO.	1.16B		-			-
FRONTIER BIOTECHNOLOGIES INC.	1.07B	-	-	-	-	-	-	-
HK INNO.N CORPORATION	1B		BBB
Average	5.9B		A
Weighted average by Cap.			A